Showing results (531-540 of 561) with videos related to
Sort By:
Pageof 57
The Lancet. Oncology|March 30, 2019
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 studyJohn N Primrose, Richard P Fox, Daniel H Palmer, et al.Leukemia & Lymphoma|July 16, 2021
A phase 1/2 study of the combination of acalabrutinib and vistusertib in patients with relapsed/refractory B-cell malignanciesGraham P Collins, Tracy N Clevenger, Kathleen A Burke, et al.The Lancet. Oncology|June 24, 2014
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trialGary Middleton, Paul Silcocks, Trevor Cox, et al.Nature Medicine|November 8, 2016
Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastasesSophia Frentzas, Eve Simoneau, Victoria L Bridgeman, et al.European Journal of Cancer (Oxford, England : 1990)|February 12, 2025
Disease-free survival as surrogate for overall survival in esophageal cancer: An individual patient data meta-analysis of neoadjuvant chemotherapy and chemoradiotherapyNicolas Cabrit, Maurice Cheugoua-Zanetsie, Jayne Tierney, et al.JAMA Network Open|August 2, 2024
Preoperative Chemoradiotherapy vs Chemotherapy for Adenocarcinoma of the Esophagogastric Junction: A Network Meta-AnalysisUlrich Ronellenfitsch, Juliane Friedrichs, Emilie Barbier, et al.The New England Journal of Medicine|December 12, 2017
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's LymphomaJoseph M Connors, Wojciech Jurczak, David J Straus, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 5, 2024
Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III TrialDaniel H Palmer, Richard Jackson, Christoph Springfeld, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 19, 2023
Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction CarcinomaMatthieu Faron, Maurice Cheugoua-Zanetsie, Jayne Tierney, et al.Gastroenterology|November 9, 2017
MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in CholangiocarcinomaAndrea Lampis, Pietro Carotenuto, Georgios Vlachogiannis, et al.Pageof 57